longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Charles River Laboratorie

CRL

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -55.86, within the reasonable range, cheaper than 77.05% of the time in the past 5 years, and the industry ranks 53/59, the industry Median -1.52.

-55.86xP/E
$279.01Stock price
$-5.00Earnings per share
-55.86xP/E
Stock price$279.01Earnings per share$-5.00

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
23.05x
Typical range
-58.51x–28.10x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
010203040

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
LZAGYUSLonza
-339.57x--$46.80B
TEMUSTempus AI
-55.02x1.23%$14.00B
CRLUSCharles River Laboratorie
-55.86x225.72%$13.32B
TXGUS10X Genomics
-137.19x107.32%$10.31B
AVTRUSAvantor
-17.67x142.83%$10.21B
BRKRUSBruker
-87.77x7.71%$9.38B
ADPTUSAdaptive Biotechnologies
-69.63x39.98%$4.45B
ABCLUSAbcellera Biologics
-24.92x34.69%$4.10B
ALMRUSAlamar Biosciences
-48.98x80.55%$2.43B
FTREUSFortrea
-22.35x93.77%$1.90B
MRVIUSMaravai LifeSciences
-24.06x65.83%$1.86B
PSNLUSPersonalis
-16.18x20.05%$1.73B
AZTAUSAzenta
-12.03x180.77%$1.48B
CYRXUSCryoport
-19.66x156.25%$892.44M
CTKBUSCytek Biosciences
-8.52x33.98%$686.31M
OABIUSOmniAb
-15.04x35.96%$665.89M
EVOUSEvotec SE
-2.39x390.22%$547.02M
DNAUSGinkgo Bioworks
-1.85x35.20%$537.38M
TKNOUSAlpha Teknova
-26.70x5.80%$447.76M
PACBUSPacific Biosc California
-3.22x75.82%$422.73M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.